Nattokinase Market Report 2025 (Global Edition)

Global Nattokinase Market Report 2024 Market Size Split by Purity (2, 000 to 5, 000 FU, 5, 000 to 10, 000 FU, 10, 000 to 15, 000 FU, 15, 000 to 20, 000 FU), by Functions (Stabilizers, Antithrombotic A...

Nattokinase Market Report Description

We have various report editions of Nattokinase Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Nattokinase Market Insights Video

Competitive Landscape of the Nattokinase Market

The competitive landscape for the Nattokinase market includes significant competitors such as Japan Bio Science Laboratory, JBSL-USA, and Sungen Bioscience, which dominate due to their large product portfolios and strong distribution networks. These companies prioritize product quality, research, and new uses in pharmaceuticals, nutraceuticals, and dietary supplements. Emerging players, notably in Asia-Pacific, are stepping up rivalry with cost-effective production and novel formulas. The market is also being driven by rising demand for natural and functional components in dietary supplements. Strategic collaborations, mergers, and acquisitions are widespread as businesses attempt to increase market share and capitalize on expanding health-conscious consumer trends worldwide.

In March 2022, Daiwa Health Development, the U.S. subsidiary of the well-known Japanese company Daiwa Pharmaceutical Co., Ltd., revealed announced that it created a new groundbreaking supplement to promote brain health. The new product, "Daiwa Brain Health®," incorporates Hokkaido Scallop Oil Plasmalogen (HSOP™), which has been demonstrated to boost memory and cognitive performance. (Source: https://www.businesswire.com/news/home/20220310005906/en/Daiwa-Health-Development-Introduces-Ground-Breaking-Brain-Supplement ) In May 2022, Gnosis by Lesaffre, a global supplier of vitamin K2, has expanded its operations by acquiring NattoPharma, another well-known supplier. Vitamin K2 is an important component for cardiovascular and bone health, but it is not found in sufficient levels in the modern diet. Supplementation is important because few foods, such as natto, are naturally abundant in vitamin K2. The acquisition enables Gnosis to provide the most comprehensive portfolio of solutions tailored to various market and consumer needs. (Source: https://gnosisbylesaffre.com/blog/gnosis-by-lesaffre-enhances-vitamin-k2-offering-with-acquisition-of-nattopharma/ ) In May 2021, Compagnie Des Levures Lesaffre, a French corporation, has acquired the remaining 23% ownership in NattoPharma ASA, a Norwegian biotechnology company. (Source: https://www.lesaffre.com/press-room/lesaffre-expands-its-development-in-human-nutrition-and-health-with-the-acquisition-of-nattopharma-in-norway/)

Top Companies Market Share in Nattokinase Industry: (In no particular order of Rank)

• Japan Bio Science Laboratory Co.
• Ltd.
• Novonesis Group (MenaquinGold)
• Creative Enzymes
• Weidan Biotechnology Co.
• Ltd.
• BIO-CAT
• Bioven Ingredients
• Eiffel Biotech
• Daiwa Pharmaceutical Co. Ltd.
• Contek Life Science Co.
• Ltd.
• Sungen Bioscience Co.
• Ltd
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Nattokinase Market

Which Region Dominates the Nattokinase Market in 2024?

According to Cognitive Market Research, North America currently dominates the Nattokinase market, and the region is expected to have significant growth during the projected period. A significant health and wellness trend drives the market in North America. Consumers are increasingly seeking natural health supplements to improve their overall well-being, which drives increased demand for nattokinase. The region has a high rate of cardiovascular disease, with heart disease being the primary cause of death. The demand for efficient preventive and therapeutic remedies is increasing the use of nattokinase.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The importance of cardiovascular health is becoming more widely recognized throughout the region. As customers become more health-conscious, the need for natural and effective health supplements such as nattokinase increases. Furthermore, Japan is a significant manufacturer of nattokinase, ensuring a consistent supply of high-quality products. The existence of established manufacturers, as well as the availability of raw materials at reasonable costs, help to strengthen the market.

The current report Scope analyzes Nattokinase Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Nattokinase

According to Cognitive Market Research, the global Nattokinase market size was estimated at USD 35.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 14.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Nattokinase market with a market size of USD 11.24 million in 2024 and is projected to grow at a CAGR of 6.5%during the forecast period. Natural supplements such as Nattokinase are in high demand in the US due to increased knowledge of heart health and prevention.
• The Canada Nattokinase market had a market share of USD 7.5% million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Canada's aging population is seeking natural remedies for cardiovascular health, leading to increased usage of Nattokinase products.
• The Mexico Nattokinase market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1.30 million in 2024.

Europe Nattokinase

According to Cognitive Market Research, the global Nattokinase market size was estimated at USD 35.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 10.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• The United Kingdom Nattokinase market had a market share of USD 1.79 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. United Kingdom Nattokinase's popularity in functional food items is driven by an increase in demand for foods that provide additional health advantages.
• The France Nattokinase market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 0.98 million in 2024.
• According to Cognitive Market Research, the German Nattokinase market size was valued at USD 2.11 million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period. In Germany, a strong tradition of health and wellness promotes the consumption of natural remedies, including Nattokinase.
• The Italy Nattokinase market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 0.92 million in 2024.
• The Russia Nattokinase market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 1.66 million in 2024.
• The Spain Nattokinase market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 0.88 million in 2024
• The Luxembourg Nattokinase market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 0.33 million in 2024.
• The Portugal Nattokinase market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 0.22 million in 2024.
• The Greece Nattokinase market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 0.13 million in 2024.
• The Rest of Europe's Nattokinase market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1.66 million in 2024.

Asia Pacific Nattokinase

According to Cognitive Market Research, the global Nattokinase market size was estimated at USD 35.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 8.19 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Nattokinase market size was valued at USD 3.68 million in 2024 and is projected to grow at a CAGR of 10.% during the forecast period. The integration of Nattokinase into traditional Chinese medicine boosts acceptance and utilization.
• The Japan Nattokinase market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 1.13 million in 2024.
• The India Nattokinase market had a market share of USD 0.98 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. India's Increasing incidences of heart diseases propel demand for natural cardiovascular solutions like Nattokinase.
• The South Korean Nattokinase market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 0.82 million in 2024.
• The Australian Nattokinase market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 0.43 million in 2024.
• The South East Asia Nattokinase market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 0.56 million in 2024.
• The Rest of Asia Pacific Nattokinase market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 0.58 million in 2024.

South America Nattokinase

According to Cognitive Market Research, the global Nattokinase market size was estimated at USD 35.6 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 1.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Nattokinase market size was valued at USD 0.76 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Nattokinase is gaining popularity among Brazilian consumers due to their preference for natural health products.
• Argentina's Nattokinase market had a market share of USD 0.30 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Argentina's rising personal disposable income enables consumers to invest in health supplements.
• Colombia Nattokinase market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 0.16 million in 2024.
• Peru Nattokinase market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 0.15 million in 2024.
• Chile Nattokinase market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 0.13 million in 2024.
• The Rest of Latin America's Nattokinase market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 0.29 million in 2024.

Middle East and Africa Nattokinase

According to Cognitive Market Research, the global Nattokinase market size was estimated at USD 35.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 0.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

• The GCC Countries Nattokinase market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 0.30 million in 2024. Nattokinase sales flourish due to the presence of major market players.
• The Egypt Nattokinase market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 0.07 million in 2024.
• The South Africa Nattokinase market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 0.11 million in 2024. Nattokinase sales flourished in South Africa due to increasing demand and regulatory support.
• The Turkey Nattokinase market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 0.06 million in 2024.
• The Nigeria Nattokinase market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 0.07 million in 2024.
• The Rest of the MEA Nattokinase market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 0.08 million in 2024.

Nattokinase Market Analysis

Nattokinase Market Type Segment Analysis

According to Cognitive Market Research, 2,000 to 5,000 FU are likely to dominate the Nattokinase Market over the forecast period. Demand for Nattokinase with potency levels ranging from 2,000 to 5,000 FU (Fibrinolytic Units) is increasing, owing to its appropriate dosage for cardiovascular health and blood clot prevention. These potency ranges are recommended in dietary supplements, particularly among consumers seeking natural options for heart health. The rise of health-conscious people, notably in North America and Europe, has increased demand for supplements with this FU spectrum.

The 5,000 to 10,000 FU is the fastest-growing segment in the Nattokinase Market. The demand for Nattokinase in the 5,000 to 10,000 FU (Fibrinolytic Units) range is rapidly increasing, particularly among health enthusiasts wanting robust cardiovascular assistance. This concentration is preferred for its increased fibrinolytic activity, making it ideal for people who want to manage blood circulation better and lower the danger of clotting. Consumer choice is being driven by a growing knowledge of the health benefits of higher FU levels, including enhanced circulation and heart health.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Nattokinase Industry. Request a Free Sample PDF!

Nattokinase Market Function Segment Analysis

According to Cognitive Market Research, The Blood Pressure Regulators segment holds the largest market share. The Nattokinase market is seeing an increase in demand for blood pressure regulators, driven by rising hypertension rates and a growing consumer preference for natural health solutions. Nattokinase's fibrinolytic activities have been linked to improved cardiovascular health and lower blood pressure. Nattokinase pills are becoming more popular as people look for new ways to manage their hypertension. Furthermore, the aging population and growing awareness of lifestyle-related health conditions drive up demand.

In the Nattokinase market, the rapidly growing sector is the Anti-Inflammatory Agents category. The demand for anti-inflammatory medications in the Nattokinase market is rising as consumers become more aware of the link between inflammation and chronic diseases. Nattokinase is known for its anti-inflammatory qualities, which can benefit cardiovascular health and overall well-being. Nattokinase is becoming increasingly popular among health-conscious people due to the growing trend of using natural supplements instead of traditional pharmaceuticals. Furthermore, increased rates of inflammatory illnesses, such as arthritis and cardiovascular disease, are driving demand for anti-inflammatory drugs.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Nattokinase Application Segment Analysis

Nattokinase Market Application Segment Analysis

According to Cognitive Market Research, the Nutraceuticals (Formulations) segment holds the largest share of the market. The market for nutraceutical formulations, including Nattokinase, is expanding, owing to the growing preference among consumers for preventative health treatments and natural supplements. Nattokinase is regarded for its possible health benefits, such as cardiovascular support and anti-inflammatory activity. As consumers become more health-conscious, there is a growing trend of including Nattokinase into daily health routines to promote heart health and overall well-being.

In the Nattokinase Market, the Pharmaceutical (Formulations) has been expanding at a rapid pace. The demand for Nattokinase-containing pharmaceutical formulations is increasing, owing to its therapeutic potential in the management of cardiovascular diseases. As research demonstrates Nattokinase's efficacy in boosting fibrinolysis and maintaining healthy blood circulation, pharmaceutical companies are becoming more interested in creating targeted treatments. Regulatory approvals and clinical endorsements strengthen Nattokinase's credibility in pharmaceutical applications.

• Nutraceuticals (Formulations)
• Pharmaceutical (Formulations)

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion